Evaluating neurometabolic networks for predicting survival in colorectal cancer
Official title: An Observational Study on the Prognostic Value of Neurometabolic Networks in Colorectal Cancer
Run by The First Affiliated Hospital of Zhengzhou University · NCT06930586 · Data updated 2026-11-12
This study is testing a new way to predict survival in colorectal cancer patients by looking at how different networks in the body interact and affect outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 213 (estimated) |
| Sponsor | The First Affiliated Hospital of Zhengzhou University Academic / other |
| Locations | 1 site (Henan, Henan) |
| Status | Recruiting |
| Started | March 1, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | April 30, 2025 |
| Trial ID | NCT06930586 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are male and female patients aged 18 and older who have been diagnosed with rectal cancer.
✕Probably not a fit
Patients with colorectal cancer who are not eligible due to age or diagnosis may not receive any benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the prognostic value of neurometabolic networks in predicting overall survival for patients with colorectal cancer (CRC). It will evaluate the area under the curve (AUC) of a model called BRIDGE and compare its predictive capabilities against existing clinical prediction models. The study focuses on understanding the complex interactions within the gastrointestinal ecosystem and their implications for tumorigenesis and patient outcomes. By adopting a systemic perspective, the research seeks to improve early detection and management strategies for CRC.
Why it matters
Potential benefit: If successful, this study could lead to improved survival predictions for colorectal cancer patients, enabling more personalized treatment approaches.
How similar studies have gone: Other studies have shown promise in using neurometabolic networks for cancer prognosis, but this specific approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Male/Female subjects with rectal cancer of at least 18 years of age will be enrolled in this trial.
Where it's running
-
Pet/ct
Henan, Henan, China Recruiting
Study contacts
- Study coordinator: Yujie Bai
- Email: baiyujie1010@163.com
- Phone: +8617803883306
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exploration of whole-brain radiotherapy with PD-1 inhibitors for brain injury in SCLC
This study tests whether adding PD-1 inhibitors to chemotherapy and prophylactic brain irradiation helps some small cell lung cancer patients protect the brain.
-
Informational Needs of Caregivers of Patients in Neuro Rehab: Validating the QBI-R/V
This study tests a caregiver questionnaire (QBI-R and QBI-V) to see how well it measures caregivers’ informational needs during neuromotor rehabilitation.
-
Can a bedside brain scan (fNIRS) detect activity in healthy people and in people with disorders of consciousness
This observational study tests whether functional near-infrared spectroscopy (fNIRS) can measure brain activity at the bedside in healthy adults and in patients with disorders of consciousness in the Neuro-ICU.
-
The Coma Family Program: a resilience program for caregivers of patients with severe brain injury
This program tests whether the Coma Family Program can better reduce emotional distress in caregivers of patients with severe acute brain injury compared to a health education control.
-
Program to restore resilience and reduce PTSD after military sexual trauma or intimate partner violence with brain injury
This trial tests whether adding a web-based emotion regulation program to exposure therapy helps female Veterans with military sexual trauma or intimate partner violence and a history of brain injury reduce PTSD symptoms.
-
Q Therapeutic System to improve arm and hand function after chronic stroke
This trial will try the Q Therapeutic (BQ 3.0) electromagnetic stimulation system with guided arm exercises to see if it improves upper limb function in people 6 months to 5 years after a stroke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.